| ACN | acetonitrile |
| AF | annulus fibrosus |
| AGC | automatic gain control |
| ANOVA | analysis of variance |
| BrdU | bromodeoxyuridine |
| CEP | cartilaginous endplate |
| DAPI | 4′,6-diamidino-2-phenylindole |
| DCFH-DA | 2′,7′-dichlorodihydrofluorescein diacetate |
| dd | double-distilled |
| DMM | destabilization of the medial meniscus |
| DOX | doxorubicin |
| ECM | extracellular matrix |
| ERKs | extracellular signal-regulated kinases |
| FA | formic acid |
| FBS | fetal bovine serum |
| GAPDH | glyceraldehyde-3-phosphate dehydrogenase |
| IVD | intervertebral disc |
| JNKs | c-Jun N-terminal kinases |
| LC-HRMS | liquid chromatography-high resolution mass spectrometry |
| LD50 | median lethal dose |
| LOD | limit of detection |
| LOQ | limit of quantification |
| MAPK | MAP kinase |
| MMP | matrix metalloproteinase |
| MRM | multiple reaction monitoring |
| MTT | methylthiazolyldiphenyl-tetrazolium bromide |
| NP | nucleus pulposus |
| OA | osteoarthritis |
| PBS | phosphate buffered saline |
| QC | quality control |
| ROS | reactive oxygen species |
| SIPS | stress-induced premature senescence |
| SPE | solid phase extraction |
| TGF-β1 | transforming growth factor β1 |
| TIMP1 | tissue inhibitor of metalloproteinase 1 |